Sugi Predict

Sugi Predict / Compounds / SCHEMBL29569549

SCHEMBL29569549

SCHEMBL29569549

CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]4(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@@H](CO)O[C@]5(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O5)O4)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(C)=O

nearest known ligand 0.67

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.67
▸ MAG P20916 6/20 0.51
▸ SELP P16109 4/20 0.50
▸ SELL P14151 2/20 0.50
▸ SELE P16581 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12313945 0.97 SIGLEC7 (0.62) SIGLEC7MAGSELPSELLSELE
SCHEMBL30654063 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL29358949 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL30653001 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL30652800 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL30651821 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL20455660 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL30655024 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL30650616 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL
SCHEMBL30654173 0.96 SIGLEC7 (0.65) SIGLEC7MAGSELPSELL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220288095-A1 SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS LIFESCIENCE AS (NO) 2022-09-15 — — US claimed
EP-4003365-A1 SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS Lifescience AS (NO) 2022-06-01 — — EP claimed
CN-114450026-A Sialic acid for use in the treatment of psoriasis 生命科学股份有限公司 2022-05-06 — — CN claimed
WO-2026090438-A1 COMPOSITIONS AND METHODS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME DIRECT BIOLOGICS, LLC (US) 2026-04-30 — — WO disclosed
US-20220288095-A1 SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS LIFESCIENCE AS (NO) 2022-09-15 — — US disclosed
EP-4003365-A1 SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS Lifescience AS (NO) 2022-06-01 — — EP disclosed
CN-114450026-A Sialic acid for use in the treatment of psoriasis 生命科学股份有限公司 2022-05-06 — — CN disclosed
Send feedback